Observations placeholder
Prazepam
Identifier
002212
Type of Spiritual Experience
Background
A description of the experience
Prazepam is marketed under the trade names Centrac, Centrax, Demetrin, Lysanxia, Mono Demetrin, Pozapam, Prasepine, Prazene, Reapam and Trepidan . It is a prodrug for desmethyldiazepam which is an active metabolite of prazepam. Desmethyldiazepam is responsible for the therapeutic effects of prazepam. It is marketed solely for anxiolytic use and is indicated for the short term treatment of anxiety. After short term therapy the dose is usually gradually tapered off to reduce or avoid any withdrawal or rebound effects. Desmethyldiazepam, the active metabolite, has a very long half life of 29 to 224 hours
On Jan, 10, 2017 1,326 people reported to have side effects when taking Prazepam. Among them, 7 people (0.53%) have Hallucination
On Jan, 30, 2017 1,326 people reported to have side effects when taking Prazepam. Among them, 1 person (0.08%) has Hallucination, Auditory